| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 157,408 shares worth roughly $644K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.27 | $71,717.74 | -0.2% | +24.9% | -23.7% | |
| Aug 29, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 6,000 | $7.56 | $45,376.20 | -1.1% | -13.9% | -36.6% | |
| Aug 20, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $7.12 | $81,532.40 | -0.2% | -14.8% | -33.4% | |
| Aug 14, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 30,000 | $6.35 | $190,434.00 | -2.2% | +20.7% | -10.2% | |
| Aug 8, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 50,000 | $6.86 | $343,000.00 | -6.2% | +5.0% | -19.3% | |
| Aug 6, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $6.82 | $78,083.42 | -0.2% | -1.0% | -18.3% | |
| Jul 25, 2024 | Marriott Tina73 | President and COO | Sale+OE10b5-1 | 6,000 | $8.13 | $48,809.40 | -1.1% | -21.4% | -19.4% | |
| Jul 23, 2024 | Borgeson Blake69 | Director | Sell10b5-1 | 11,447 | $8.48 | $97,040.80 | -0.2% | -21.2% | -25.1% | |
| Jul 11, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell10b5-1 | 100,000 | $7.48 | $747,500.00 | -11.6% | -19.9% | -31.2% | |
| Jul 10, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE10b5-1 | 30,000 | $7.28 | $218,353.50 | -2.2% | -10.9% | -21.0% |